BE706469A - - Google Patents
Info
- Publication number
- BE706469A BE706469A BE706469DA BE706469A BE 706469 A BE706469 A BE 706469A BE 706469D A BE706469D A BE 706469DA BE 706469 A BE706469 A BE 706469A
- Authority
- BE
- Belgium
- Prior art keywords
- tetracycline
- pyrrolidine
- succinate
- chloramphenicol
- methyl
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 9
- 229960004357 chloramphenicol succinate Drugs 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- LIRCDOVJWUGTMW-ZWNOBZJWSA-N Chloramphenicol succinate Chemical compound OC(=O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 LIRCDOVJWUGTMW-ZWNOBZJWSA-N 0.000 claims 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 description 8
- 229960002180 tetracycline Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- 229930101283 tetracycline Natural products 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- 150000003522 tetracyclines Chemical class 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK9901160 | 1960-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE706469A true BE706469A (mo) | 1968-03-18 |
Family
ID=8157176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE706469D BE706469A (mo) | 1960-09-08 | 1967-11-14 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE706469A (mo) |
-
1967
- 1967-11-14 BE BE706469D patent/BE706469A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Selye | On the protective action of testosterone against the kidney damaging effect of sublimate | |
| Montes et al. | Additive effect of DL-penicillamine plus Prussian blue for the antidotal treatment of thallotoxicosis in rats | |
| Bonta et al. | Haemorrhagic mechanisms of some snake venoms in relation to protection by estriol succinate of blood vessel damage | |
| US3042706A (en) | Process for purifying pyrethrum extracts | |
| Gomez et al. | Embryotoxic and teratogenic effects of intraperitoneally administered metavanadate in mice | |
| Anderson et al. | Toxicological studies on synthetic glycerin | |
| US2144552A (en) | Alkanol-amine salt of mandelic acid | |
| BARGER et al. | The alkaloids of Mitragyna rotundifolia. I | |
| CH639083A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| Sourkes et al. | Correlation between the acute toxicity and the rate of elimination of tartaric acid and certain of its esters | |
| Cretcher et al. | Glycol esters of certain aromatic acids | |
| Clover | Periodides of Carbonyl Compounds. | |
| CH127779A (fr) | Procédé de préparation d'un dérivé pipéridique substitué en position B et Y. | |
| CH394199A (fr) | Procédé de préparation de nicotinate de lysine | |
| BE897217A (fr) | NOUVEAU MEDICAMENT ANTI-INFLAMMATOIRE, ANALGESIQUE ET ANTIPYRETIQUE A BASE DE (P-CHLOROBENZOYL-1, METHYL- 2- Methoxy-5) Indole-3 Acetate de P-Acetamidophenol | |
| US1178941A (en) | Preparation for infecting vermin with disease. | |
| FR2535205A1 (fr) | Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation | |
| US2320630A (en) | Taeniacide | |
| AT233561B (de) | Verfahren zur Herstellung von neuen, alkylierten 6-(5-Nitro-2-furyl)-as-triazin-3,5-dionen | |
| AT218015B (de) | Verfahren zur Herstellung neuer 1-Acyl-1-(β-cyanoäthyl)-2-(5'-nitrofurfuryliden)-hydrazine | |
| Keplinger et al. | The pharmacological effects of magnesium arsenate phosphor upon experimental animals | |
| CH385885A (de) | Verfahren zur Herstellung des 1-Carbamyl-1-(B-cyanäthyl)-2-(5'-nitrofurfuryliden)-hydrazins | |
| US1486468A (en) | Process for rendering durable extracts of drugs | |
| BE563114A (mo) | ||
| AT167093B (de) | Verfahren zur Herstellung des neuen, antiepileptisch wirkenden 1,3,3-Trimethyl-2,4-dioxopiperidins |